Your browser doesn't support javascript.
loading
SLC16A2 mutations in two Japanese patients with Allan-Herndon-Dudley syndrome.
Yamamoto, Toshiyuki; Shimojima, Keiko; Umemura, Ayako; Uematsu, Mitsugu; Nakayama, Tojo; Inoue, Ken.
Afiliación
  • Yamamoto T; Tokyo Women's Medical University Institute for Integrated Medical Sciences , Tokyo, Japan.
  • Shimojima K; Tokyo Women's Medical University Institute for Integrated Medical Sciences , Tokyo, Japan.
  • Umemura A; Department of Pediatrics, Central Hospital, Aichi Human Service Center , Kasugai, Japan.
  • Uematsu M; Department of Pediatrics, Tohoku University School of Medicine , Sendai, Japan.
  • Nakayama T; Department of Pediatrics, Tohoku University School of Medicine , Sendai, Japan.
  • Inoue K; National Institute of Neuroscience, National Center for Neurology and Psychiatry , Kodaira, Japan.
Hum Genome Var ; 1: 14010, 2014.
Article en En | MEDLINE | ID: mdl-27081503
ABSTRACT
Allan-Herndon-Dudley syndrome (AHDS) is a neurodevelopmental disorder that manifests as intellectual disability and motor developmental delay. Thyroid hormone transporter dysfunction due to SLC16A2 mutation is the underlying cause of this disorder. We identified a novel (P537del) and a recurrent (A150V) SLC16A2 mutation in Japanese AHDS patients from two different families. A150V co-segregated with S33P. Both patients showed similar clinical features including severe neurological features and delayed myelination. Thyroid function showed a common finding of elevated T3 levels. No clear genotype-phenotype correlation was observed in patients with SLC16A2 alterations.

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Hum Genome Var Año: 2014 Tipo del documento: Article País de afiliación: Japón

Texto completo: 1 Bases de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Hum Genome Var Año: 2014 Tipo del documento: Article País de afiliación: Japón